obesity

News

Lilly-backed scheme aims to help UK improve obesity care

Tens of thousands of NHS patients living with obesity could get help to reduce their weight through a partnership between the UK and Eli Lilly.

News

Apple partners with FuturHealth on weight loss

An alliance between Apple and FuturHealth will combine GLP-1 weight-loss treatment with the tech giant's Fitness+ subscription.

News

Lilly weakens on oral weight-loss drug data

Shares in Eli Lilly have come under pressure after reporting the results of a phase 3 trial of oral weight-loss candidate orforglipron.

News

Novo Nordisk weakens again on interim results readout

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the first half of this year.

News

Noom Med app and accompanying GLP-1 implements

Noom expands its GLP-1 range with 'microdose' package

Noom is offering 'microdoses' of semaglutide at a knock-down price, claiming they can prevent side effects but remain effective for weight loss.

News

NICE calls for better care after weight-loss therapy ends

People completing a course of obesity medication, or completing a weight-management programme, need better support, according to NICE.

Lilly-backed scheme aims to help UK improve obesity care

Apple partners with FuturHealth on weight loss

Lilly weakens on oral weight-loss drug data

Novo Nordisk weakens again on interim results readout

Noom expands its GLP-1 range with 'microdose' package

NICE calls for better care after weight-loss therapy ends

Rhapsido is first drug cleared for chronic hives disorder SD

Discover a new era of healthcare panel engagement: Grounded ...

obesity

Editor's Picks